Hainan Shuangcheng Pharmaceuticals Co., Ltd.

¥7.78As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002693Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.42%)
Div yield —
ROE 8.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.61
PE TTM 67.49
TSR TTM (6.49%)
Mkt cap ¥3.226B
ROIC 7.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.67
24.35%
(33.23%)
Buy 9|7|2|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.14
0.16
0.16
10.67%
13.54%
18.28%
19.89%
Revenue¥M
303.4
316.3
314.5
326.5
6.82%
12.38%
9.24%
12.85%
Peers (US$483.6M)
Cap (US$)
PE
495.8M
16.44x
476.6M
—
Capital
TTM
5Y
10Y
Leveragex
3.065
0.549
0.523
EBIT/Intx
5.065
0.355
0.370
Own earn%
206.76
(245.95)
(195.34)
Sh yield%
23.12
39.80
42.44
Owners
Insiders/Inst%
0.20
38.38
Short interest%
5.48
SBC / revenue%
1.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
21–25
$1 testx
0.4
Incr. ROIC%
4